Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-27 2019-08-21 87684
RATIO-IPRA SAL UDV 0.5MG 2.5MG SOLUTION Resolved 2019-07-02 2019-07-16 88167
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Resolved 2019-08-06 2019-11-19 90935
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-08-22 2019-10-10 92198
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2019-08-22 2019-10-24 92229
TEVA-LATANOPROST 0.05MG SOLUTION Resolved 2019-09-05 2020-07-10 93159
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-12 2019-11-22 93650
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-26 2019-11-14 94840
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95373
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-11-01 95381
ACT PROGESTERONE INJECTION 50MG SOLUTION Resolved 2019-10-24 2020-05-14 97147
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-02-21 98179
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-01-27 98185
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-11-07 2020-05-29 98188
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Resolved 2019-11-21 2020-01-09 99441
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-28 2020-06-25 99955
TEVA-COMBO STERINEBS 0.5MG 2.5MG SOLUTION Resolved 2019-12-19 2020-09-03 101702
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-01-09 2020-02-21 102893

Showing 721 to 740 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2018-10-19 2018-10-19 64993
TEVA-NORFLOXACIN 400MG TABLET Discontinued 2018-10-19 2018-10-19 65013
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65020
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65023
TEVA-PIOGLITAZONE 15MG TABLET Discontinued 2018-10-19 2018-10-19 65026
TEVA-PIOGLITAZONE 30MG TABLET Discontinued 2018-10-19 2018-10-19 65030
TEVA-PIOGLITAZONE 45MG TABLET Discontinued 2018-10-19 2018-10-19 65033
TEVA-QUETIAPINE 100MG TABLET Discontinued 2018-10-19 2018-10-19 65036
TEVA-QUETIAPINE 200MG TABLET Discontinued 2018-10-19 2018-10-19 65039
TEVA-QUETIAPINE 25MG TABLET Discontinued 2018-10-19 2018-10-19 65044
TEVA-QUETIAPINE 300MG TABLET Discontinued 2018-10-19 2018-10-19 65047
ACT ZOPICLONE 5MG TABLET Discontinued 2018-10-22 2018-10-22 65191
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65213
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218
ACT ETIDROCAL 400MG 500MG TABLET Discontinued 2019-02-21 2019-03-01 76486
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313

Showing 141 to 160 of 250